For the Inventor, By the Inventor

Enter assignee name

Fort Worth, TX, United States of America

Alcon Laboratories, Inc.

Calculating rank

USPTO Granted Patents = 449

% Expired Patents = 0.89

CIPO Patents = 2

EPO Patents = 2

Trademarks = 21

Forward Citations = 20,183

Loading Chart...

Loading Chart...

330 inventors (with patents filed for the assignee):

Mark R Hellberg (32 out of 89 patents)

Billie M York (25 out of 29 patents)

Abbot F Clark (20 out of 58 patents)

4. Verney L Sallee (20 out of 22 patents)

5. Bahram Asgharian (19 out of 35 patents)

6. Stella M Robertson (19 out of 19 patents)

7. Thomas R Dean (18 out of 26 patents)

8. John M Yanni (16 out of 53 patents)

9. Raymond E Conrow (15 out of 29 patents)

10. Bor-Shyue Hong (15 out of 16 patents)

11. Joonsup Park (15 out of 20 patents)

12. Louis DeSantis, Jr (14 out of 20 patents)

13. Paul W Zinke (14 out of 21 patents)

14. Masood A Chowhan (13 out of 41 patents)

15. Ronald P Quintana (13 out of 13 patents)

Core Competencies:

Glaucoma Treatments

Contact Lens Care

Surgical Devices

Ocular Hypertension

Prostaglandins

Ophthalmic Compositions

Intraocular Lens

Antioxidant Agents

Neuroprotective Agents

Enzyme Compositions

Sustained Release

Liquid Enzymes

449 patents: Sort by Forward Citations

1. 9078887 - Bicyclic heteroaryl inhibitors of PDE4 (2015-07-14),

2. 6890484 - In line test device and methods of use (2005-05-10),

3. 6863073 - Laminar cribosa puncture device, methods related to use of such a device and methods for treating central retinal vein occulsions (2005-03-08),

4. 6759190 - Test strip for detection of analyte and methods of use (2004-07-06),

5. 6630135 - Use of sustained release antibiotic compositions in ophthalmic surgical procedures (2003-10-07),

6. 6565808 - Line test device and methods of use (2003-05-20),

7. 6509355 - Treatment of disorders of the outer retina (2003-01-21),

8. D468437 - Test platform (2003-01-08),

9. 6486208 - Sustained release, and comfortable opthalmic composition and method for ocular therapy (2002-11-26),

10. D464141 - Test device platform (2002-10-09),

11. 6403590 - Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia (2002-06-11),

12. 6399107 - Use of inhibitors of gag synthesis for the treatment of corneal haze (2002-06-04),

13. 6358897 - Alkyl trypsin compositions and methods of use in contact lens cleaning and disinfecting systems (2002-03-19),

14. 6353014 - 15-ketal postaglandins for the treatment of glaucoma or ocular hypertension (2002-03-05),

15. 6353000 - 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension (2002-03-05),

Company Overview

Alcon Laboratories, Inc., headquartered in Fort Worth, Texas, specializes in ocular therapeutics, focusing on innovative solutions for eye care. The company develops and manufactures a range of products, including glaucoma treatments, contact lens care solutions, and surgical devices. Alcon is dedicated to addressing conditions such as ocular hypertension and enhancing patient outcomes through advanced ophthalmic compositions and intraocular lenses. Its commitment to research and development positions it as a leader in the field of eye health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

449 Patents

#2 in Fort Worth, TX

#67 in Texas

#1,069 in US

#2,127 in the World

Fort Worth, TX, United States of America

Alcon Laboratories, Inc.

Forward Citations = 20,183

330 inventors:

Mark R Hellberg (32 out of 89 patents)

Billie M York (25 out of 29 patents)

Abbot F Clark (20 out of 58 patents)

4. Verney L Sallee (20 out of 22 patents)

5. Bahram Asgharian (19 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alcon Laboratories, Inc.. Retrieved from https://idiyas.com/company/alcon-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…